Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Cited by (1,000)

Items 601–700 of 1,000

1. Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan
   Isao Kamae, Yoichiro Hashimoto, Yukihiro Koretsune, Norio Tanahashi, Tatsunori Murata, Hemant M. Phatak, Larry Z. Liu, Ann Chuo Tang, Peter Feng Wang, Ken Okumura · 2015 · Clinical Therapeutics
2. Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral‐Anticoagulation‐Naïve Patients With Atrial Fibrillation: A Randomized Trial
   Günther Silbernagel, David Spirk, A. Hager, Iris Baumgärtner, Nils Kucher · 2016 · Journal of the American Heart Association
3. Efficacy and Safety of Rivaroxaban and Warfarin in the Perioperative Period of Catheter Ablation for Atrial Fibrillation – Outcome Analysis From a Prospective Multicenter Registry Study in Japan –
   Ken Okumura, Kazutaka Aonuma, Koichiro Kumagai, Kenzo Hirao, Koichi Inoue, Masaomi Kimura, Yasushi Miyauchi, Eiki Tsushima, for the JACRE Investigators · 2016 · Circulation Journal
4. Determination of edoxaban equivalent concentrations in human plasma by an automated anti-factor Xa chromogenic assay
   Ling He, Jarema Peter Kochan, Min Lin, Alexander G. Vandell, Karen S Brown, François Depasse · 2017 · Thrombosis Research
5. The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice
   Watanabe, Masaki, Chaudhry, Saqib A., Adil, Malik Muhammad, Alqadri, Syeda Laila, Majidi, Shahram, Semaan, Edouard, Qureshi, Adnan I. · 2015 · Journal of Vascular Surgery
6. Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease
   Kristina Wasmer, Michael Unrath, Julia Köbe, Nasser M. Malyar, Eva Freisinger, Matthias Meyborg, Günter Breithardt, Lars Eckardt, Holger Reinecke · 2015 · International Journal of Cardiology
7. Antiplatelet Agents for Stroke Prevention
   Samuel Yip, Oscar Benavente · 2011 · Neurotherapeutics
8. Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome
   Ritin Bomb, Carrie S. Oliphant, Rami N. Khouzam · 2015 · The American Journal of Cardiology
9. Determination of Direct Oral Anticoagulants from Human Serum Samples
   Sandra Kraemer, Shanshan Du, Christina Giese, Astrid Schulze, R. Kraemer, Christel Weiß, Job Harenberg · 2013 · Seminars in Thrombosis and Hemostasis
10. Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non‐valvular atrial fibrillation
    Giulia Bertozzo, Giacomo Zoppellaro, Serena Granziera, Lucia Marigo, K. Rossi, Florinda Petruzzellis, Egle Perissinotto, Enzo Manzato, Giovanni Nante, Vittorio Pengo · 2016 · Journal of Thrombosis and Haemostasis
11. Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients
    Chao‐Lun Lai, Ho‐Min Chen, Min‐Tsun Liao, Ting‐Tse Lin, K. Arnold Chan · 2017 · Journal of the American Heart Association
12. Risk Factors for Delayed Bleeding after Therapeutic Gastrointestinal Endoscopy in Patients Receiving Oral Anticoagulants: A Multicenter Retrospective Study
    Kimitoshi Kubo, Mototsugu Kato, Katsuhiro Mabe, Naohiko Harada, Yoichiro Iboshi, Takashi Kagaya, Masayoshi Ono, Tatsuya Toyokawa, Haruhiro Yamashita, Toshio Kuwai et al. · 2019 · Digestion
13. New options with dabigatran etexilate in anticoagulant therapy
    Lars Mäegdefessel · 2010 · Vascular Health and Risk Management
14. Bleeding of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
    Joey SW Kwong, Yat‐Yin Lam, Bryan P. Yan, Cheuk‐Man Yu · 2012 · Cardiovascular Drugs and Therapy
15. Secondary prevention of stroke
    Niall MacDougall, Sanjay Amarasinghe, Keith W. Muir · 2009 · Expert Review of Cardiovascular Therapy
16. Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage
    Pauline Renou, Jean‐Benoît Thambo, Xavier Iriart, Stéphanie Nicot, Nathanaël Kaboré, Zakaria Jalal, Stéphane Olindo, Sabrina Debruxelles, Mathilde Poli, François Rouanet et al. · 2016 · Journal of Stroke and Cerebrovascular Diseases
17. Historical perspective and future direction of coagulation research
    Hidehiko Saito, Tadashi Matsushita, Tetsuhito Kojima · 2011 · Journal of Thrombosis and Haemostasis
18. Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice
    Michael R. Preusch, Nicholas M. Ieronimakis, Errol S. Wijelath, Jerry L. Ricks, Florian Bea, Morayma Reyes, Joanne van Ryn, Michael E. Rosenfeld, Sara Cabbage · 2015 · Drug Design Development and Therapy
19. Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
    Gregory Y.H. Lip · 2013 · Journal of Thrombosis and Haemostasis
20. Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
    Winnie W. Nelson, Marco DiBonaventura, Lewis Kopenhafer, Jiyoon C. Choi · 2014 · Patient Preference and Adherence
21. Predictors of Long‐term Maintenance of Normal Sinus Rhythm After Successful Electrical Cardioversion
    Basil Abu‐El‐Haija, MICHAEL C. GIUDICI · 2014 · Clinical Cardiology
22. Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
    Sylvia K. Haas, Christoph Bode, Bo G Norrving, Alexander G.G. Turpie · 2014 · Vascular Health and Risk Management
23. Effectiveness and safety of rivaroxaban vs warfarin in people with non‐valvular atrial fibrillation and diabetes: an administrative claims database analysis
    Craig Ian Coleman, Thomas J. Bunz, Daniel Eriksson, Anna Meinecke, Nitesh A. Sood · 2018 · Diabetic Medicine
24. Non–Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function
    So‐Ryoung Lee, Eue‐Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Myung‐Jin Cha, Seil Oh, Gregory Y.H. Lip · 2019 · Stroke
25. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
    James Beharry, Michael J. Waters, Roy Drew, John Fink, Duncan Wilson, Bruce C.V. Campbell, Mark William Parsons, Timothy John Kleinig, Teddy Y. Wu · 2020 · Stroke
26. Left Atrial Appendage Closure
    Inder M. Singh, David R. Holmes · 2010 · Current Cardiology Reports
27. Safety and efficacy of P2Y12inhibitor monotherapy in patients undergoing percutaneous coronary interventions
    Mattía Galli, Davide Capodanno, Felicita Andreotti, Filippo Crea, Dominick Joseph Angiolillo · 2020 · Expert Opinion on Drug Safety
28. Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy
    Nathalie C. V. Péquériaux, Rob Fijnheer, Eugenie F. A. Gemen, Arjan D. Barendrecht, Friedo Wilhelm Dekker, Raymond Theodorus Krediet, Jaap J. Beutler, Elisabeth Wilhelmina Boeschoten, Mark Roest · 2011 · Nephrology Dialysis Transplantation
29. Clinical Trials Update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, Partial Ventricular Support, FIX-HF-5, Vagal Stimulation, REVIVAL-3, Pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA
    John G.F. Cleland, Alison P. Coletta, Andrew L. Clark, Damien Cullington · 2009 · European Journal of Heart Failure
30. Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk
    Gregory Y.H. Lip · 2010 · EP Europace
31. Management and 1-Year Outcomes of Patients With Atrial Fibrillation in the Middle East: Gulf Survey of Atrial Fibrillation Events
    Zubaid, Mohammad, Rashed, Wafa A., Alsheikh-Ali, Alawi A., Al-Zakwani, Ibrahim, AlMahmeed, Wael, Shehab, Abdullah, Sulaiman, Kadhim, Qudaimi, Ahmed Al, Asaad, Nidal, Amin, Haitham · 2015 · Angiology
32. Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda
    Chen-Huan Chen, Mien‐Cheng Chen, Harry H. Gibbs, Sun Uck Kwon, Sidney T. Lo, Young Keun On, Azhari Rosman, Nijasri Charnnarong Suwanwela, Ru‐San Tan, Louie S. Tirador et al. · 2015 · International Journal of Cardiology
33. Antithrombotic Therapy After Coronary Stenting in Patients With Nonvalvular Atrial Fibrillation
    Kay Woon Ho, Joan Ivanov, Xavier Freixa, Christopher B. Overgaard, Mark Osten, Douglas J. Ing, Eric M. Horlick, Karen Mackie, Peter H. Seidelin, Vladimír Džavík · 2012 · Canadian Journal of Cardiology
34. A New Landscape for Stroke Prevention in Atrial Fibrillation
    Amitava Banerjee, Francisco R. Marín, Gregory Y.H. Lip · 2011 · Stroke
35. Prasugrel: A Critical Comparison with Clopidogrel
    Kurt M. Reinhart, Charles Michael White, William L. Baker · 2009 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
36. An Updated Review of Target‐Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes
    Christina L. Cove, Elaine M. Hylek · 2013 · Journal of the American Heart Association
37. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study
    Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Luca Scrucca, Serenella Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini · 2019 · International Journal of Cardiology
38. Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation
    Donald Lynch, David M Dantzler, Mark A. Robbins, David Xiao-Ming Zhao · 2013 · Journal of Thrombosis and Thrombolysis
39. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
    Marco Alessandrini, Mamoonah Chaudhry, Tyren M. Dodgen, Michael Sean Pepper · 2016 · OMICS A Journal of Integrative Biology
40. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy
    Salma Imran Patel, Chad Christian Cherington, Robyn Marie Scherber, Kathryn Barr, Ryan Y. McLemore, Donald Edward Morisky, Stephen Cha, Farouk Mookadam, Fadi Elias Shamoun · 2017 · Journal of Osteopathic Medicine
41. The left atrial appendage exclusion for prophylactic stroke reduction (LEAAPS) trial: Rationale and design
    Richard Paul Whitlock, Patrick M. McCarthy, Marc Gerdisch, Basel Ramlawi, John Hunter Alexander, Ibrahim Sultan, David Z. Rose, Jeff S. Healey, Yashasvi Awasthi, Emilie P. Belley‐Côté et al. · 2024 · American Heart Journal
42. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy
    Gregory Y.H. Lip, Lars Hvilsted Rasmussen, Sandra Olsson, Sofia Zetterstrand, Christina Stahre, Anders L. Bylock, Maria Aunes-Jansson, Ulf G. Eriksson, Karin Wåhlander · 2010 · Thrombosis Research
43. Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events
    Guillaume Paré, Stephanie A. Ross, Shamir R. Mehta, Salim Yusuf, Sonia Savitri Anand, Stuart J. Connolly, Keith A.A. Fox, John W. Eikelboom · 2012 · Circulation Cardiovascular Genetics
44. Secondary Intracerebral Hemorrhage Due to Early Initiation of Oral Anticoagulation After Ischemic Stroke
    Michael Gliem, Derik Franz Hermsen, Nico van Rooijen, Hans‐Peter Hartung, Sebastian Jander · 2012 · Stroke
45. Efficacy and Safety of Direct Oral Anticoagulants in Kidney Transplantation: A Single-center Pilot Experience
    Juliette Léon, Laurent Sabbah, Olivier Aubert, Dany Anglicheau, Xavier Delavenne, Julien Zuber, Lucile Amrouche, Anne Scemla, Geltrude Giura, Gillian Divard et al. · 2020 · Transplantation
46. Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study
    Gavino Casu, Giuseppe D’Angelo, Fabrizio Ugo, Federico Ronco, Federico Simonetto, Marco Barbierato, Valeria Magni, Giacomo Giovanni Boccuzzi, Alberto Margonato, Francesco Moroni et al. · 2020 · International Journal of Cardiology
47. Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)
    Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen Joost Bax, Carina Blomström‐Lundqvist, Giuseppe Boriani, Manuel Castellà, Gheorghe‐Andrei Dan, Polychronis Dilaveris et al. · 2021 · Revista Española de Cardiología
48. Proton-Pump Inhibitors in Patients Requiring Antiplatelet Therapy: New FDA Labeling
    David A. Johnson, ROBERT J. CHILTON, Harley R. Liker · 2014 · Postgraduate Medicine
49. Effect of Addition of Clopidogrel to Aspirin on Subdural Hematoma: Meta-Analysis of Randomized Clinical Trials
    Majid F. Bakheet, Lesly A. Pearce, Robert G. Hart · 2014 · International Journal of Stroke
50. Antithrombotic drugs, patient characteristics, and gastrointestinal bleeding: Clinical translation and areas of research
    Alessandro Di Minno, Gaia Spadarella, Domenico Prisco, Antonella Scalera, Elena Ricciardi, Giovanni Di Minno · 2015 · Blood Reviews
51. Mechanical Thrombectomy in Patients with Acute Ischemic Stroke on Anticoagulation Therapy
    David Černík, Daniel Šaňák, Petra Divišová, Martin Köcher, Filip Cihlář, Jana Zapletalová, Tomáš Veverka, Andrea Prcúchová, Dušan Ospalík, Marie Černá et al. · 2018 · CardioVascular and Interventional Radiology
52. Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy
    Guozhen Cui, Luchen Shan, Lin Guo, Ivan Keung Chu, Guohui Li, Quan Quan, Yun Zhao, Cheong Meng Chong, Zaijun Zhang, Pei Yu et al. · 2015 · Scientific Reports
53. Anticoagulation and atrial fibrillation
    Diener, C · 2010 · Schweizer Archiv für Neurologie und Psychiatrie
54. A Randomized, Double-Blind, Placebo-Controlled Study of Rebamipide for Gastric Mucosal Injury Taking Aspirin With or Without Clopidogrel
    Katsuyuki Tozawa, Tadayuki Oshima, Takuya Okugawa, Tomohiro Ogawa, Yoshio Ohda, Toshihiko Tomita, Nobuyuki Hida, Hirokazu Fukui, Kazutoshi Hori, Jiro Watari et al. · 2014 · Digestive Diseases and Sciences
55. Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study
    Tze‐Fan Chao, Chia‐Jen Liu, Ta‐Chuan Tuan, Kang-Ling Wang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Tzeng‐Ji Chen, Chern‐En Chiang et al. · 2016 · Mayo Clinic Proceedings
56. Influence of proton pump inhibitors on blood dabigatran concentrations in Japanese patients with non‐valvular atrial fibrillation
    Tasuku Kuwayama, Hiroyuki Osanai, Masayoshi Ajioka, Kotaro Tokuda, Hirofumi Ohashi, Akihiro Tobe, Tsutomu Yoshida, Tomohiro Masutomi, Takahiro Kambara, Yosuke Inoue et al. · 2017 · Journal of Arrhythmia
57. Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal
    Peter Dieter Schellinger, Georgios K. Tsivgoulis, Thorsten Steiner, Martin Köhrmann · 2018 · Journal of Stroke
58. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation
    Frida Labori, Josefine Persson, Carl Bonander, Katarina Jood, Mikael Svensson · 2021 · European Heart Journal
59. Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions
    Pankaj Mathur, Hakan Paydak, Sharmilan Thanendrarajan, Frits van Rhee · 2015 · Clinical Lymphoma Myeloma & Leukemia
60. Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation
    Yat‐Yin Lam, Terry K.W. Ma, Bryan P. Yan · 2010 · International Journal of Cardiology
61. Significant Increase in Clopidogrel Use Across U.S. Children’s Hospitals
    Chiara Gentilomo, Yuan-Shung Vera Huang, Leslie J. Raffini · 2010 · Pediatric Cardiology
62. Atherosclerosis and thromboembolic risk in atrial fibrillation: Focus on peripheral vascular disease
    Eva Jover, Francisco R. Marín, Vanessa Roldán, Silvia Montoro‐García, Mariano Valdés, Gregory Y.H. Lip · 2012 · Annals of Medicine
63. Treatment of Risk Factors to Prevent Stroke
    Junya Aoki, Ken Uchino · 2011 · Neurotherapeutics
64. Screening for atrial fibrillation in Canadian pharmacies: an economic evaluation
    Jean‐Éric Tarride, Lisa Dolovich, Gordon Blackhouse, Jason R. Guertin, Natasha Burke, Veena Manja, Alex Grinvalds, Ting Lim, Jeff S. Healey, Roopinder Kaur Sandhu · 2017 · CMAJ Open
65. Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention
    Fei Gao, Hua Shen, Zhi Jian Wang, Shi Wei Yang, Xiao Li Liu, Yu Jie Zhou · 2015 · Contemporary Clinical Trials
66. Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines
    Kristina Wasmer, Lars Eckardt · 2011 · EP Europace
67. Comparing the 2010 North American and European Atrial Fibrillation Guidelines
    Anne M. Gillis, Allan Cameron Skanes · 2011 · Canadian Journal of Cardiology
68. Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective
    Raúl Altman, Hector O Vidal · 2011 · Thrombosis Journal
69. Composite risk scores and composite endpoints in the risk prediction of outcomes in anticoagulated patients with atrial fibrillation
    Amitava Banerjee, Laurent Fauchier, Anne Bernard-Brunet, Nicolas Clémenty, Gregory Y.H. Lip · 2014 · Thrombosis and Haemostasis
70. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation
    Emily Claire O'Brien, DaJuanicia N. Holmes, Laine Elliott Thomas, Gregg C. Fonarow, Larry A. Allen, Bernard John Gersh, Peter Russell Kowey, Daniel E. Singer, Michael D. Ezekowitz, Gerald V. Naccarelli et al. · 2018 · Circulation
71. Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials
    Alexander Philipp Benz, Isabelle Johansson, Willem J.M. Dewilde, Renato D. Lópes, Roxana Mehran, Samantha Sartori, Nikolaus Sarafoff, Satoshi Yasuda, William F McIntyre, Jeff S. Healey et al. · 2021 · European Heart Journal - Cardiovascular Pharmacotherapy
72. Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients
    Akiva Diamond, Wyatt P. Bensken, Long Vu, Weichuan Dong, Siran M. Koroukian, Paolo Fabrizio Caimi · 2023 · JACC CardioOncology
73. Effects of Combined Aspirin and Clopidogrel Therapy on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
    Yu-Hao Zhou, Xin Wei, Jian Lu, Xiao‐Fei Ye, Mei-Jing Wu, Jinfang Xu, Ying-Yi Qin, Jia He · 2012 · PLoS ONE
74. Supervised Patient Self-Testing of Warfarin Therapy Using an Online System
    Lre Bereznicki, SL Jackson, Gregory Mark Peterson · 2013 · Journal of Medical Internet Research
75. Inefficacy Interim Monitoring Procedures in Randomized Clinical Trials: The Need to Report
    Edward L. Korn, Boris Freidlin · 2011 · The American Journal of Bioethics
76. Advancing Cardiovascular Research
    Michael S. Lauer · 2012 · CHEST Journal
77. Options to Overcome Clopidogrel Response Variability
    Kyung Woo Park, Hyo-Soo Kim · 2012 · Circulation Journal
78. Left Atrial Appendage Occlusion for Stroke Prevention
    Oluseun O. Alli, David R. Holmes · 2015 · Current Problems in Cardiology
79. The Future of Antiplatelet Therapy in Cardiovascular Disease
    Carlo Patrono, Bianca Rocca · 2010 · Annual Review of Medicine
80. Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation
    Birgit Steppich, Franziska Dobler, L. C. Brendel, Gabriele Hessling, S. Braun, Anna-Lena Steinsiek, Isabel Deisenhofer, Agon Hyseni, Mark Roest, Ilka Ott · 2017 · Journal of Thrombosis and Thrombolysis
81. Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects
    Paola Altieri, Maria Bianca Bertolotto, Patrizia Fabbi, Elena Sportelli, Manrico Balbi, Francesco Santini, Claudio Brunelli, Marco Canepa, Fabrizio Montecucco, Pietro Ameri · 2018 · International Journal of Cardiology
82. Cardioembolic Stroke
    Cumara B. O’Carroll, Kevin M. Barrett · 2017 · CONTINUUM Lifelong Learning in Neurology
83. Residual risk for secondary ischemic events in patients with atherothrombotic disease: Opportunity for future improvements in patient care
    Carl J. Pepine · 2010 · Annals of Medicine
84. Risk-Benefit Profile of Warfarin Versus Aspirin in Patients With Heart Failure and Sinus Rhythm: A Meta-analysis
    Meng Lee, J. Saver, K. Hong, Hsiu-Chuan Wu, B. Ovbiagele · 2013 · Circulation: Heart Failure
85. Erratum: Balancing ischaemia and bleeding risks with novel oral anticoagulants
    Usman Baber, Ioannis Mastoris, Roxana Mehran · 2014 · Nature Reviews Cardiology
86. Patient Satisfaction with Warfarin- and Non–Warfarin-Containing Thromboprophylaxis Regimens for Atrial Fibrillation
    Craig Ian Coleman, Stacey M Coleman, Julie Vanderpoel, Winnie W. Nelson, Jennifer A. Colby, Jennifer M Scholle, Jeffrey Kluger · 2013 · Journal of Investigative Medicine
87. Clopidogrel: A Pharmacogenomic Perspective on its Use in Coronary Artery Disease
    Chris M. Terpening · 2010 · Clinical Medicine Insights: Cardiology
88. Assessment of oral antithrombotic therapy by platelet function testing
    Udaya S. Tantry, Paul Alfred Gurbel · 2011 · Nature Reviews Cardiology
89. Post‐marketing surveillance on the long‐term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J‐dabigatran surveillance
    Hiroshi Inoue, Shinichiro Uchiyama, Hirotsugu Atarashi, Ken Okumura, Yukihiro Koretsune, Masahiro Yasaka, Takeshi Yamashita, Makiko Ohnishi, Nobutaka Yagi, Taku Fukaya et al. · 2016 · Journal of Arrhythmia
90. Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
    Ahmad Salah Hersi, Katherine M. Osenenko, Sid Ahmed Kherraf, Ayman Abdel Aziz, R Sambrook · 2019 · Annals of Saudi Medicine
91. Comparative Safety and Effectiveness of Direct-Acting Oral Anticoagulants Versus Warfarin: a National Cohort Study of Nursing Home Residents
    Matthew James Alcusky, Jennifer Tjia, David D. McManus, Anne Lamont Hume, Marc Fisher, Kate L. Lapane · 2020 · Journal of General Internal Medicine
92. Balancing ischaemia and bleeding risks with novel oral anticoagulants
    Usman Baber, Ioannis Mastoris, Roxana Mehran · 2014 · Nature Reviews Cardiology
93. Epidemiologic Trends in Hospitalized Ischemic Stroke from 2002 to 2010: Results from a Large Italian Population-Based Study
    Paola Santalucia, Marta Baviera, Laura Cortesi, Mauro Tettamanti, Irene Marzona, Alessandro Nobili, Emma Riva, Ida Fortino, Angela Bortolotti, Luca Giuseppe Merlino et al. · 2015 · Journal of Stroke and Cerebrovascular Diseases
94. Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice
    Kim Allen Eagle, David S. Cannom, David A. Garcia · 2010 · The American Journal of Medicine
95. Dabigatran and Thrombin Modulate Electrophysiological Characteristics of Pulmonary Vein and Left Atrium
    CHIEN‐JUNG CHANG, Yao‐Chang Chen, Yu‐Hsun Kao, Yung‐Kuo Lin, Shih‐Ann Chen, Yi‐Jen Chen · 2012 · Circulation Arrhythmia and Electrophysiology
96. Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?
    James Demetrios Douketis · 2011 · Thrombosis Research
97. A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?
    Ekrem Güler, Gamze Babür Güler, Gültekin Günhan Demır, Suzan Hatipoğlu · 2015 · The Anatolian Journal of Cardiology
98. Beware of Novel Antiplatelet Therapy in Acute Coronary Syndrome Patients With Previous Stroke
    Freek W.A. Verheugt · 2012 · Circulation
99. Comparative Effectiveness of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in the Management of Patients With Nonvalvular Atrial Fibrillation
    Joshua Pink, Munir Pirmohamed, Dyfrig Arwyn Hughes · 2013 · Clinical Pharmacology & Therapeutics
100. I. Stroke in General
     Yukito Shinohara, Takehiko Yanagihara, Koji Abe, Toshiki Yoshimine, Toshiyuki Fujinaka, Takayo Chuma, Fumio Ochi, Masao Nagayama, Akira Ogawa, Norihiro Suzuki et al. · 2011 · Journal of Stroke and Cerebrovascular Diseases